Literature DB >> 8664272

Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells.

K M Barnes1, B Dickstein, G B Cutler, T Fojo, S E Bates.   

Abstract

According to multiple reports, progesterone is not transported by P-glycoprotein (Pgp), which mediates multidrug resistance through active drug efflux. However, progesterone has been shown to block Pgp- mediated efflux of other drugs. To extend these observations and to examine the effect of modulating Pgp phosphorylation, the accumulation of progesterone and 14 other steroids in untreated and calphostin C-treated multidrug-resistant human colon carcinoma SW620 Ad300 cells was compared to the accumulation in parental SW620 cells. However, the accumlation of more hydrophilic steroids was reduced by as much as 50%. Progesterone and progesterone-like compounds, however were potent inhibitors of Pgp-mediated vinblastine efflux; increased antagonism correlated with increased steroid hydrophobicity. Treatment with calphostin C, a PKC inhibitor which decreases Pgp phosphorylation, increased progesterone efflux, modulated Pgp antagonism by steroids, and inhibited photoaffinity labeling of Pgp by progesterone. These results extend previous observations that Pgp can mediate the transport of, and be antagonized by, a variety of steroids and that these properties vary with both steroid's hydrophobicity and the phosphorylated state of Pgp.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8664272     DOI: 10.1021/bi952380k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

1.  Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

Authors:  R B Kim; C Wandel; B Leake; M Cvetkovic; M F Fromm; P J Dempsey; M M Roden; F Belas; A K Chaudhary; D M Roden; A J Wood; G R Wilkinson
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Physicochemical properties and transport of steroids across Caco-2 cells.

Authors:  Fried Faassen; Jan Kelder; Johan Lenders; Rob Onderwater; Herman Vromans
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

3.  Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception.

Authors:  Ute I Schwarz; Barbara Büschel; W Kirch
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

Review 4.  Proteins of multiple classes may participate in nongenomic steroid actions.

Authors:  Cheryl S Watson; Bahiru Gametchu
Journal:  Exp Biol Med (Maywood)       Date:  2003-12

5.  Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.

Authors:  G Conseil; H Baubichon-Cortay; G Dayan; J M Jault; D Barron; A Di Pietro
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

6.  Structural determinants of P-glycoprotein-mediated transport of glucocorticoids.

Authors:  Charles R Yates; Cheng Chang; Jeffrey D Kearbey; Kazuto Yasuda; Erin G Schuetz; Duane D Miller; James T Dalton; Peter W Swaan
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

7.  P-glycoprotein acts as an immunomodulator during neuroinflammation.

Authors:  Gijs Kooij; Ronald Backer; Jasper J Koning; Arie Reijerkerk; Jack van Horssen; Susanne M A van der Pol; Joost Drexhage; Alfred Schinkel; Christine D Dijkstra; Joke M M den Haan; Teunis B H Geijtenbeek; Helga E de Vries
Journal:  PLoS One       Date:  2009-12-08       Impact factor: 3.240

8.  Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients.

Authors:  Wai-Johnn Sam; Christine E Chamberlain; Su-Jun Lee; Joyce A Goldstein; Douglas A Hale; Roslyn B Mannon; Allan D Kirk; Yuen Yi Hon
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

9.  The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.

Authors:  Alexia Garrigues; Alexandre E Escargueil; Stephane Orlowski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

Review 10.  Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease.

Authors:  Staffan Edsbäcker; Tommy Andersson
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.